Here's What Larry Merlo has to say about CVS's 2013 Outlook
"Well, keep in mind as you cycle into ’13 you’ve got a couple things happening. First and foremost, you have continued generic (GER) expansion, number one. And number two is you’re comping against some share gains, high share gains as we move into 2013 versus what we gained in 2012. And then finally you have one less day in ’13 than you have in ’12 due to leap year."
Mr. Merlo has access to CVS's January Sales numbers, we don't. He knows what's coming! WAG's amazing sales numbers are inversely related to CVS's sales numbers. Buy CVS stock at your own risk. Don't say you weren't warned, by me and Larry Merlo.
I guess Merlo can always fall back on this statement in defending himself against class action lawsuits. Don't understand how this stock actually still has buyers, with so much going against it. By refusing full disclosure, CVS is effectively hiding it's poor comp numbers until May 1. They have until then to get their spin doctors to conjure up some glittering generalities to disguise the poor performance.